Fundz

Cyrus Biotechnology reported raising $1.11 Million in an initial SEC Form D filing, from an offering of $1.5 Million

PRIVATEJul 16, 2025$1.1M of $1.5M raised

Amount Raised

$1.11 Million

$1.11 Million sold, per SEC Form D (first sale Jul 1, 2025)

Round Type

Seed

SeattleInformation TechnologyBiotechnology

Who to call at Cyrus Biotechnology, Inc., and when

A new round usually means Cyrus Biotechnology, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cyrus Biotechnology, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cyrus Biotechnology, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cyrus Biotechnology, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cyrus Biotechnology, Inc.

Location

1201 2nd Ave, Suite 900

Seattle, Washington, United States

About

Cyrus Biotechnology is a pre-clinical-stage biotech company combining protein design and screening to create novel biologics for serious unmet medical needs. Using this approach, we are developing an early pipeline of innovative programs in multiple indications. We are also partnering with leading biotech and pharma companies and research institutes to bring collaborative programs forward from discovery to the clinic.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cyrus Biotechnology, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsLucas, CEO and Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Cyrus Biotechnology, Inc.'s next move

See what Strategic adds

Cyrus Biotechnology, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.